/stocks — the workspaceLOADING

ADTX · All filings · Read this filing

What changed 10-K

Item 5. Market for Registrant’s Common Equity

2025-03-31 compared with 2024-04-16 · 22 added, 41 removed, 25 unchanged (72% of the section changed)

5 unchanged sentences

our common stock.

As of April 12, 2024, there

were approximately 168 record holders of our common stock.

As of April 12, 2024, there were 5, 13, and 1 holder(s) of Series A-1

Convertible Preferred Stock, Series B-1 Convertible Preferred Stock, and Series B-2 Convertible Preferred Stock, respectively.

number of holders of our common stock is greater than this number of record holders, and includes stockholders who are beneficial owners,

but whose shares are held in street name by brokers or held by other nominees.

This number of holders of record also does not include

stockholders whose shares may be held in trust by other entities.

As of March 31, 2025, there were approximately 168 record holders

of our common stock.

As of April 12, 2024, there were 5, 13, and 1 holder(s) of Series A-1 Convertible Preferred Stock, Series B-1 Convertible

Preferred Stock, and Series B-2 Convertible Preferred Stock, respectively.

The actual number of holders of our common stock is greater

than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers

or held by other nominees.

This number of holders of record also does not include stockholders whose shares may be held in trust by other

Dividend Policy

7 unchanged sentences

Recent Sales of Unregistered Securities

On March 17, 2023, the Company issued a consultant

4,675 shares of common stock for services rendered.

On December 19, 2023, the Company issued a consultant

70,000 shares of common stock for services rendered.

On January 31, 2022 the Company

issued a consultant 1 shares of common stock for services rendered.

On February 28, 2022 the Company

issued a consultant 1 shares of common stock for services rendered.

On March 31, 2022 the Company

issued a consultant 1 shares of common stock for services rendered.

On December 12, 2022 the Company

issued a consultant 1 shares of common stock for services rendered.

On December 27, 2023, the Company

issued a consultant 1 shares of common stock for services rendered.

On March 17, 2023, the Company

issued a consultant 1 shares of common stock for services rendered.

On December 20, 2023, the Company

issued a consultant 7 shares of common stock for services rendered.

The issuances above were made pursuant

7 unchanged sentences

our registered equity securities during the period covered by this Annual Report.

Use of Proceeds from Initial Public Offering

On July 2, 2020, we completed

our initial public offering (“IPO”).

In connection therewith, we issued 614 Units (the “IPO Units”), excluding

the underwriters’ option to cover overallotments, at an offering price of $18,000.00 per IPO Unit, resulting in gross proceeds of

approximately $11.0 million.

The IPO Units issued in the IPO consisted of one share of common stock, one Series A warrant, and one Series

The Series A warrants originally had an exercise price of $18,000.00 and a term of 5 years.

In addition, we issued a Unit Purchase

Option at an exercise price of $22,500.00 per unit to the underwriters to purchase up to 34 units, with each unit consisting of (i) one

share of common stock and (ii) one Series A Warrant.

On August 19, 2020 we modified the exercise price of the Series A Warrants from $18,000.00

per share to $9,000.00 per share.

The term of the Series A Warrants was not modified.

The Series B warrants have an exercise price of

$22,500.00 per share, a term of 5 years and contain a cashless exercise option upon certain criteria being met.

As of December 31, 2020,

substantially all of the Series B warrants issued in the IPO have been exercised pursuant to a cashless provision therein.

We received net proceeds of

$8.5 million in the IPO, after deducting underwriting discounts and commissions and issuance expenses borne by us.

No payments were made

by us to directors, officers or persons owning ten percent or more of our common stock or to their associates, or to our affiliates, other

than payments in the ordinary course of business to officers for salaries and to non-employee directors pursuant to our director compensation

Dawson James Securities, Inc.

acted as lead book-running manager of the offering and as representative of the underwriters for

the offering.

There has been no material

change in the planned use of proceeds from our IPO from that described in the final prospectus related to the offering, dated June 29,

2020, as filed with the SEC.

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.